Page 640 - Multidisipliner Covid 19
P. 640

BÖLÜM  35






         34. Yu CM, R Wong RSM, Wu EB, Kong SL, Wong J, Yip GWK, et al.Cardio
             vascularcomplications of severe acuterespiratorysyndrome.Postgrad
             Med J.2006; 82(964): 140–144
         35. Wu CI, Postema PG,  Arbelo E, Behr ER, Bezzina CR, Napolitano C,
             et al.SARS-CoV-2, COVID-19 andinheritedarrhythmiasyndromes.
             HearRhythm 2020. https://doi.org/10.1016/j.hrthm.2020.03.024
         36. Beach SR, Celano CM, Sugrue AM, Adams C., Ackerman MJ, Nosewor-
             thy PA, et al.QT Prolongation, Torsades de Pointes, andPsychotropic
             Medications: A 5-Year Update Psychosomatics2018; 59(2):105-122.
         37. Lee IC, Huo TI, Huang YH.GastrointestinalandLiverManifestations
             in Patientswith COVID-19 J ChinMedAssoc. 2020; 83(6):521-523.
         38.  Xie H, Zhao J, Lian N, Lin S, Xie Q, Zhuo H. Clinicalcharacteristics of
             non-ICU hospitalizedpatientswithcoronavirusdisease 2019 andliverin-
             jury: A retrospectivestudy.LiverInt. 2020; 40(6):1321-1326.
         39. Goldberg J, Ernst C. Managingthe Side Effects of PsychotropicMedica-
             tions. 2nd Ed. Washington DC: AmericanPsychiatricAssociation Pub-
             lishing; 2019: 209-244.
         40.  Fanelli V, Fiorentino M,  Cantaluppi V,  Gesualdo L,  Stallone G,  Ronco
             C,  et al.Acutekidneyinjury in SARS-CoV-2 infectedpatients.
             CritCare.2020; 24(1):155.
         41. Baig  AM, Khaleeq A, Ali U, Syeda H. Evidence of the COVID-19 vi-
             rustargetingthe CNS: tissuedistribution, host-virusinteraction, andpro-
             posedneurotropicmechanisms. ACS ChemNerosci. 2020 11(7):995-998.
         42. Li YC, Bai WL,HashikawaT. Theneuroinvasivepotential of SARS-CoV2
             mayplay a role in therespiratoryfailure of COVID-19 patients. J Med
             Virol.2020; 92(6):552-555.
         43. MaoL , Jin H, Wang M, Hu Y, Chen S, He Q, et al.Neurologicmanifes-
             tations of hospitalizedpatientswithcoronavirusdisease 2019 in Wuhan,
             China. JAMA 2020;77(6):683-690
         44.  HelmsJ , Kremer S, Merdji H, Clere-Jehl R, Schenck M, Kummerlen C,
             et al.Neurologicfeatures in severe SARS-CoV-2 infection. N Engl J Med
             2020; 382:2268-2270.
         45.  Kotfis K, RobersonSW , Wilson JE, Dabrowski W, Pun BT, Ely EW.
             COVID-19: ICU deliriummanagementduring SARS-CoV-2 pandemic.
             CritCare 2020; 24(1):1-9.
         46. Wu CS, Wang SC, Yeh IJ, Liu SK. Comparative risk of seizurewithuse
             of first- andsecond-generationantipsychotics in patientswith




                                                                        639
   635   636   637   638   639   640   641   642   643   644   645